Neurofibromin regulates glioma cell growth through the AKT/mTOR pathway [20, 21], such that Nf1−/− astrocytes exhibit AKT/mTOR hyperactivation relative to Nf1+/+ (wild-type) astrocytes (Supplementary Figure 4A). Here, MTOR is linked to central nervous system cancer.